探索对生物疗法的看法:加拿大严重喘患者的定性研究
Andrea Bever1, Jessica Dunne1, Jenna Reynolds2
1Broadstreet HEOR, 201-343 Railway St, Vancouver, BC, Canada.
Advances in therapy
|February 13, 2024
概括
生物疗法为严重喘患者提供了显著的好处,但进入和坚持障碍仍然存在. 患者的优先事项包括方便,财务支持和解决安全问题,以获得更好的治疗结果.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 患者报告的结果
- 药理学 药理学是指药理学的学科.
背景情况:
- 生物疗法可以改善严重的喘症状,减少喘恶化.
- 关于患者对严重喘生物治疗的看法,数据有限.
- 了解患者的偏好对于优化新生物疗法至关重要.
研究的目的:
- 探索加拿大严重喘患者在生物治疗方面的偏好和优先事项.
- 确定影响采用和坚持生物疗法的以患者为中心的因素.
主要方法:
- 对18名患有严重喘的加拿大人进行了定性采访 (其中一些人先前有生物学经验).
- 半结构面试探讨了日常生活,治疗经验和对生物药物的看法.
- 反思性主题分析确定了患者观点中的关键主题.
主要成果:
- 生物药物被认为可能改变生活,但不是普遍有效或可获得的.
- 识别了生物处方和遵守的障碍,包括不熟悉性和资格问题.
- 患者的偏好超越了方便,包括安全,管理和财务支持.
结论:
- 生物制剂的临床益处与患者控制喘的目标一致.
- 对于缺乏有意义的症状改善或面临进入障碍的患者,存在治疗缺口.
- 解决患者的优先事项,如家庭选择,财政援助和安全信息是有效的生物治疗的关键.
更多相关视频
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
298
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
298
Antiasthma Drugs: β2-Adrenoceptor Agonists
265
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
265
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
247
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
247
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
206
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
206


